Time is money and chatbots like OpenAI’s ChatGPT and Google Gemini have become valuable tools. They can write code, summarize long emails, and even find patterns in large volumes of data. However, as ...

AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...